Archive for the 'ovarian cancer For patients' Category
Ovarian cancer care
One, paclitaxel and cisplatin in the treatment of advanced ovarian cancer care <BR> <BR> 1990s Taxol is more of the treatment of advanced ovarian cancer drug effective, and its unique mechanism is a new type of anti-tubulin role of antitumor drugs. Cisplatin for inorganic platinum metal complex, the cell cycle-specific drug, can inhibit DNA synthesis, combined with their synergies to enhance the effectiveness of [1]. In Division I from July 1996 to July 1998 to 15 cases of advanced ovarian cancer patients with Taxol and cisplatin in the treatment of satisfactory results.
One, information and Methods
Tags: administration, age, anti, blood, body, cancer, care, cases, cause, cell, cells, chemotherapy, cisplatin, clinical, confidence, days, diet, dose, drug, drugs, eat, ert, estrogen, family, fat, gene, group, growth, incidence, infusion, injection, intravenous, life, mass, metastasis, method, ovarian, paclitaxel, pain, patients, physical, poor, positive, psychological, quality, rate, reduce, response, skin, surface, surgery, survival, symptoms, taxol, therapy, time, toxicity, treatment, tumor, tumors, womenComfort theory in ovarian cancer patients dying of
Ovarian cancer is a common cancer of female genital mutilation one of the incidence of cervical cancer and after cancer of the uterus. Ovarian cancer incidence rate of 1.8% in early ovarian cancer prognosis good, and Phase III ovarian cancer prognosis after the five-year survival rate is about 15% but more than 70% of patients at diagnosis is already late, so who died from ovarian cancer for the first of Gynecologic Oncology [1 ]. The definition of terminal care: treatment without significance that foresee only survived six months which is death [2]. In China, no time limit and dying. In general, patients in the active treatment no hope to survive until the end of this period of life known as the terminal phase, which is the period dying nursing care. At this point control pain and symptomatic treatment, so that patients have the best quality of life is necessary and important. For nearly two years, in Section I of ovarian cancer patients with terminal care process, the active use of comfortable nursing theory, the patients through the psychological care, nutritional support, skin care, cancer care, patients and family members have been authorized satisfactory results.
Tags: cancer, care, diagnosis, early, eat, family, gene, incidence, life, ovarian, pain, patients, prognosis, psychological, quality, rate, skin, survival, time, treatmentAfter how the rehabilitation exercises?
Some people believe that cancer patients should not go to physical exercise on the grounds that this would accelerate the body's blood circulation, in the cancer will spread opportunity with the flow and speed, worsening of the illness. This view is without any scientific basis.
Of course, after the cancer diagnosis, treatment measures should be taken as soon as possible. Using tumor resection or radiotherapy, chemotherapy after disease control, it should be appropriate means to participate in some physical activity, and for the principle of its capabilities, gradual, to enhance immune function, increased in the blood leukocytes, and interleukin phagocytic cells and bacteria with the ability . At the same time, physical exercise can improve the body's metabolism and improve the body's resistance. Appropriate exercise can adopt the following four points, played the role of cancer prevention of cancer.
Tags: blood, body, cancer, carcinoma, cell, cells, chemotherapy, days, diagnosis, early, eat, increased, patients, physical, radiotherapy, rate, reduce, resection, surgery, surgical, therapy, time, treatment, tumorOvarian cancer prognosis and outcome
| Ovarian cancer | ||
|
The prognosis and outcome Common and prognosis factors: • clinical stage and is closely related to survival; • histological type and grade pathology and prognosis is directly related; • differentiation and biological characteristics and the prognosis also directly related to a direct impact on the survival rate and survival time. • In addition, the age factor and the prognosis of more closely. Another treatment option with a reasonable and thorough, but also directly affect the prognosis of ovarian cancer. Both the borderline epithelial ovarian cancer or other types of ovarian cancer, the need for close follow-up after treatment, such as timely found evidence of recurrence, surgery or chemotherapy again. Patients may extend life, even cured. Tumor markers for the periodic inspection, review of RII, body check and some other auxiliary are to be brought to the attention of track. Major ovarian cancer recurrence after surgery three years ago, after two exploration average recurrence time in 24 months, two exploration negative does not mean relapse. Overall the prognosis of patients with tumor stage, the residual disease after surgery at the size, pathologic classification and treatment methods, and have relations. |
||
End-stage ovarian cancer care
One, paclitaxel and cisplatin in the treatment of advanced ovarian cancer care <BR> <BR> 1990s Taxol is more of the treatment of advanced ovarian cancer drug effective, and its unique mechanism is a new type of anti-tubulin role of antitumor drugs. Cisplatin for inorganic platinum metal complex, the cell cycle-specific drug, can inhibit DNA synthesis, combined with their synergies to enhance the effectiveness of [1]. In Division I from July 1996 to July 1998 to 15 cases of advanced ovarian cancer patients with Taxol and cisplatin in the treatment of satisfactory results.
One, information and Methods
Tags: administration, age, anti, blood, body, cancer, care, cases, cause, cell, cells, chemotherapy, cisplatin, clinical, confidence, days, diet, dose, drug, drugs, eat, ert, estrogen, family, fat, gene, group, growth, incidence, infusion, injection, intravenous, life, mass, metastasis, method, ovarian, paclitaxel, pain, patients, physical, poor, positive, psychological, quality, rate, reduce, response, skin, surface, surgery, survival, symptoms, taxol, therapy, time, toxicity, treatment, tumor, tumors, womenHow to reduce the recurrence of ovarian cancer
(1). Complete removal of lesions in ovarian cancer surgery should be the primary tumor resection can see pots and peritoneal metastasis, or to residual tumor diameter is less than 2.0 to 1.5 cm. The epithelial cancer, but also for greater omentum and appendectomy.
Tags: age, anti, blood, body, cancer, cell, cells, chemotherapy, clinical, diet, drug, drugs, eat, gene, lymph, mass, metastasis, node, ovarian, patients, prognosis, rate, reduce, resection, residual, second, study, surgery, surgical, therapy, treatment, tumor, tumorsTaxol and cisplatin in the treatment of advanced ovarian cancer care
Taxol is more 1990s, the treatment of advanced ovarian cancer drug effective, and its unique mechanism is a new type of anti-tubulin role of antitumor drugs. Cisplatin for inorganic platinum metal complex, the cell cycle-specific drug, can inhibit DNA synthesis, combined with their synergies to enhance the effectiveness of [1]. In Division I from July 1996 to July 1998 to 15 cases of advanced ovarian cancer patients with Taxol and cisplatin in the treatment of satisfactory results.
Tags: administration, age, anti, blood, body, cancer, care, cases, cause, cell, chemotherapy, cisplatin, confidence, days, diet, dose, drug, drugs, eat, ert, gene, group, growth, incidence, infusion, injection, intravenous, life, metastasis, method, ovarian, paclitaxel, pain, patients, poor, psychological, rate, reduce, response, skin, surface, surgery, survival, symptoms, taxol, therapy, time, toxicity, treatment, tumor, tumors, womenTaxol combined platinum treatment of ovarian cancer care
"Nursing Care of Patients Treated With Combination Oophoroma of Taxolr and Platinum" ovarian cancer in the female genital cancer incidence rate of the two, but the mortality rate is the one. According to information at home and abroad, the survival rate of patients 5a about 30%, 70% have advanced at diagnosis [1]. Currently the disease is a better treatment after surgery and adjuvant chemotherapy. I Branch in 1996 -1997, will Taxol and cisplatin in the treatment of ovarian cancer <BR> made good effect, even on the platinum resistance there are still 20% to 30% effective. Now Taxol treatment care summarized as follows:
A clinical data and methods
1.1 clinical data: 12 patients had been diagnosed with ovarian cancer. Age 18 to 68 years old, with an average age of 43 years. Thailand used in the treatment of a total of 24 courses, the average two courses. Only two courses for Taxol alone, the rest are combined, each treatment separated three weeks to four weeks.
1.2 treatment:
1.2.1 before chemotherapy treatment: 6 hours respectively before treatment, 12 hours of oral dexamethasone 20 mg, in the half-hour before administration of oral and intravenous diphenhydramine 50 mg and cimetidine 300 mg to prevent the occurrence of allergic reactions.
1.2.2 drug preparation: Thailand concentrated on the use of PVC with a syringe preparation will liquid two phthalic acid ethyl of increase [2]. It increases in drug use should be used glass and stainless steel syringe needles, and the infusion of special filters are allocated are spent. As the Taxol is a cell-like anti-cancer drugs, so nurses in the preparation and administration must pay attention to self-protection, gloves, masks, if the skin or mucosa by pollution, should be thoroughly cleaned immediately with soap or water rinse [2].